DHA dosage and pregnancy
|
1. Predicting the effect of maternal docosahexaenoic acid (DHA) supplementation to reduce early preterm birth in Australia and the United States using results of within country randomized controlled trials. (Studies: 800 mg/day and 600 mg/day) -> |
| ||
|
2. Dose–response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight. ->
|
| ||
|
3. Target DHA level of 5 percent (of RBC) or higher reduces preterm birth risk, research finds (overview Nutrition Insight 23.1.2019) ->
|
| ||
|
4. DHA Supplementation during Pregnancy and Lactation Affects Infants’ Cellular but Not Humoral Immune Response (Study: 400 mg/day) ->
|
| ||
|
5. A Prenatal DHA Test to Help Identify Women at Increased Risk for Early Preterm Birth: A Proposal (in Nutrients 6.12.2018) ->
|
| ||
|
6. Supplementation of n-3 fatty acids during pregnancy and lactation reduces maternal plasma lipid levels and provides DHA to the infants. ->
|
| ||
|
7. Tolerable intake level in EFSA Journal 2014. ->
|
| ||
|
8. Official publication EU - 2018. ->
|
| ||
